Skip to content

Artificial intelligence-assisted risk assessment and prognostic analysis of common clinical risk factors for AIS patients with endovascular treatment

Artificial intelligence-assisted risk assessment and prognostic analysis of common clinical risk factors for AIS patients with endovascular treatment

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400085127
Enrollment
Unknown
Registered
2024-05-31
Start date
2024-06-01
Completion date
Unknown
Last updated
2024-06-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute ischemic stroke

Interventions

AI-assisted decision making:Using artificial intelligence risk assessment and prognostic prediction models to assist physicians in decision-making, risk assessment
routine treatment:Routine assessment and treatment modalities

Sponsors

Tianjin Huanhu Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: A. Patients aged greater than or equal to 18 and less than or equal to 85 years. B. Proven acute ischemic stroke within 24 hours of onset. C. New focal neurological deficits consistent with acute cerebral ischemia. D. modified Rankin score of 0-2 before onset. E. Informed consent obtained from the patient or the patient's legally authorized representative. F. All subjects or their proxies are required to sign an informed consent form.

Exclusion criteria

Exclusion criteria: A. Acute cerebral hemorrhage or subarachnoid hemorrhage, active hemorrhage or pre-existing bleeding tendency. B. non-first episode with a history of old cerebral hemorrhage/ischemia. C. Non-vascular disease causing, e.g., tumor, trauma, hematologic disease. D. Pre-existing immune disorders that confound outcome evaluation, neurological or psychiatric disorders, stroke attacks with epilepsy or other psychiatric disorders and irritable states unable to cooperate with the examination E. Coma or altered level of consciousness or unstable vital signs. F. Hepatic or renal insufficiency, active infection, severe cardiac arrhythmias. G. Women who are known to be pregnant, breastfeeding or have an active or indeterminate pregnancy test.

Design outcomes

Primary

MeasureTime frame
90-day mRS score;

Secondary

MeasureTime frame
Adverse events;

Countries

China

Contacts

Public ContactYing Huang

Tianjin Huanhu Hospital

yinghuang0000@163.com+86 138 0304 1267

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026